🇺🇸 FDA
Patent

US 10093684

Substituted imidazo[1,2-a]pyrazines as Syk inhibitors

granted A61KA61K9/0053A61P

Quick answer

US patent 10093684 (Substituted imidazo[1,2-a]pyrazines as Syk inhibitors) held by GILEAD CONNECTICUT, INC. expires Mon Oct 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
GILEAD CONNECTICUT, INC.
Grant date
Tue Oct 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K9/0053, A61P, A61P1/00, A61P11/00